Repligen Corporation Uncategorized Contracts & Agreements

Description of Certain Registrants Securities (Filed With SEC on February 26, 2020)

Letter Agreement, dated as of September 3, 2016 by and between Repligen Corporation and Ralf Kuriyel (Filed With SEC on March 1, 2019)

Amendment No. 4 to Strategic Supplier Alliance Agreement, dated February 20, 2018, by and between Repligen Sweden AB and GE Healthcare Bio-Sciences AB (Filed With SEC on May 8, 2018)

STOCKHOLDER AGREEMENT (Filed With SEC on June 23, 2017)

[Remainder of Page Intentionally Left Blank] (Filed With SEC on September 2, 2016)

1 Attachment A Purchased Material Quality Terms (Filed With SEC on May 5, 2016)

FOURTH AMENDMENT (Filed With SEC on May 9, 2014)

[Remainder of Page Intentionally Left Blank] (Filed With SEC on March 21, 2014)

Agreement (Filed With SEC on May 7, 2012)

Stairs/house (Filed With SEC on March 15, 2012)

Attachment A Purchased Material Quality Terms (Filed With SEC on March 15, 2012)

AMENDMENT NO. 1 TO STRATEGIC SUPPLIER ALLIANCE AGREEMENT (Filed With SEC on March 15, 2012)

[SIGNATURE PAGES FOLLOW] (Filed With SEC on March 15, 2012)

NOVOZYMES BIOPHARMA DK A/S, NOVOZYMES BIOPHARMA SWEDEN AB, REPLIGEN CORPORATION AND REPLIGEN SWEDENAB Asset TransferAgreement (Filed With SEC on October 28, 2011)

Attachment A Purchased Material Quality Terms (Filed With SEC on June 10, 2010)

WHENEVER CONFIDENTIAL INFORMATION IS OMITTED HEREIN (SUCH OMISSIONS ARE (Filed With SEC on August 5, 2005)

Specifications - * (Filed With SEC on June 14, 2005)

REPLIGEN CORPORATION (Filed With SEC on June 14, 2005)